Navigation Links
Skinvisible and Cambrex Enter Into Agreement to Develop Acne Products
Date:1/22/2009

u>

About Cambrex Corporation - Cambrex provides products and services to accelerate the development and commercialization of small molecule therapeutics including active pharmaceutical ingredients ("API"), advanced intermediates, enhanced drug delivery, and other products for branded and generic pharmaceuticals. www.cambrex.com

Skinvisible Pharmaceuticals, Inc. Forward-Looking Statements

This press release contains 'forward looking' statements within the meaning of Section 21A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbors created thereby. Such statements involve certain risks and uncertainties associated with an emerging company. Actual results could differ materially from those projected in the forward looking statements as a result of risk factors discussed in Skinvisible, Inc. reports on file with the U.S. Securities and Exchange Commission (including, but not limited to, a report on Form 10Q for the quarter ending September 30, 2008).

CambrexCorporation Forward-Looking Statements

This news release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and Rule 3b-6 under the Securities Exchange Act of 1934, as amended, including, without limitation, statements regarding expected performance, especially expectations with respect to sales, research and development expenditures, earnings per share, capital expenditures, acquisitions, divestitures, collaborations, or other expansion opportunities. These statements may be identified by the fact that words such as "expects", "anticipates", "intends", "estimates", "believes" or similar expressions are used in connection with any discussion of future financial or operating performance. Any forward-lookin
'/>"/>

SOURCE Skinvisible, Inc.; Cambrex Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Skinvisible Appoints Dr. Geert Cauwenbergh to Its International Advisory Board
2. Skinvisible Offers 8 Hour Photostablity for Parsol 1789
3. Skinvisible Appoints New Vice President of Business Development & Marketing
4. Skinvisible Signs Licensing Agreement for Two Acne Formulations
5. Skinvisible Appoints New Board Member
6. Skinvisible Announces Licensing Agreement for Adapalene
7. Skinvisible Signs Marketing Agreement for India
8. Skinvisible Appoints Dr. George Korkos to Its Advisory Board
9. Skinvisible to Present at Merriman Curhan Ford & Co.s Investor Summit 2007
10. Cambrex Presentation at The JPMorgan Healthcare Conference to be Webcast
11. Cambrex to Announce First Quarter 2008 Financial Results on May 1, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... According to court documents, Donna Pirolli was ... 2013 and underwent a procedure during which a duodenoscope ... Because the duodenoscope allegedly had not been properly cleaned, ... Enterobacteriaceae (CRE). , A lawsuit has been ... behalf of Ms. Pirolli alleging that Lutheran General Hospital ...
(Date:2/27/2015)... Winter is here, and with it comes harsh ... snow and ice can be harmful on a dog’s paws. ... Puppy Store is ready to help pet owners know what ... the winter time. , Ice melts can lead to several ... Ingestion of ice melt products may cause depression, loss of ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 FACE ... therapies, has announced a unique combination to take ... neck. Ultherapy Décolletage is a new treatment introduced ... noninvasive procedure specifically indicated to improve lines and ... for any person who suffers from the stubborn ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 Glidewell ... today the launch of its CloudPoint™ ... the digital production of monolithic zirconia crowns & ... means of providing the CAD/CAM-produced restorations that doctors ... portal through which cases can be scanned, managed ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 Insight ... Medical to advance the development of an in-line ... new solution is being developed in direct response ... only 73% accuracy and error margins with potentially ... error-free output measurement and provide trending data analysis ...
Breaking Medicine News(10 mins):Health News:Lawsuit Alleges Blame on Scope Manufacturer for "Superbug" Outbreak 2Health News:The Puppy Store Helps Dogs Prepare for Harsh Winter Conditions 2Health News:Face Skincare Announces New Combination Therapy 2Health News:Glidewell Laboratories Announces Release of CloudPoint™ FastScan™ and FastDesign™ 2Health News:Glidewell Laboratories Announces Release of CloudPoint™ FastScan™ and FastDesign™ 3Health News:Output Medical Joins Insight Accelerator Labs 2Health News:Output Medical Joins Insight Accelerator Labs 3
... and efficacy of first FDA-approved nebulized ... COPD -, NAPA, Calif., May 16 Dey, ... given at the International,Conference of the American Thoracic Society ... Center. One of the presentations details the,effects on dyspnea ...
... mastectomy (total breast removal) for early-stage breast cancer has ... in Rochester. The increase follows a steady decline during ... for this increase are unclear. But they have determined ... resonance imaging (MRI) prior to surgery to treat early-stage ...
... sooner if therapy is working , , FRIDAY, May 16 ... levels of circulating tumor cells can help doctors more ... with metastatic breast cancer, according to a Georgetown University ... weeks, and sometimes months, to determine if a particular ...
... /Xinhua-PRNewswire-FirstCall/ --,Shengtai Pharmaceutical, Inc. (OTC Bulletin Board: SGTI) ... distributor,of high-quality, pharmaceutical grade glucose products in China, ... March 31, 2008., Third Quarter of ... to $20.7 million -- Gross profit rose ...
... May 16 IDM Pharma, Inc.,(Nasdaq: IDMI ... Company,s lead product candidates will be made at ... annual meeting. Data presented,at the meeting will support ... L-MTP-PE, as well as patients with non-small lung,cancer ...
... wake of divorce, illness, violence and other problems that ... experience temporary separations from one or both parents before ... May/June issue of Ambulatory Pediatrics, a new, community-wide study ... at increased risk for learning difficulties and that these ...
Cached Medicine News:Health News:Clinical Trial Data for Perforomist(TM) Inhalation Solution to be Presented at ATS on May 20, 2008 2Health News:Clinical Trial Data for Perforomist(TM) Inhalation Solution to be Presented at ATS on May 20, 2008 3Health News:Clinical Trial Data for Perforomist(TM) Inhalation Solution to be Presented at ATS on May 20, 2008 4Health News:Clinical Trial Data for Perforomist(TM) Inhalation Solution to be Presented at ATS on May 20, 2008 5Health News: Mastectomies on the rise and MRI use may explain part of the trend, say Mayo researchers 2Health News: Mastectomies on the rise and MRI use may explain part of the trend, say Mayo researchers 3Health News:Blood Test Helps Docs Assess Breast Cancer Treatment 2Health News:Shengtai Pharmaceutical, Inc. Reports Third Quarter Results of Fiscal Year 2008 2Health News:Shengtai Pharmaceutical, Inc. Reports Third Quarter Results of Fiscal Year 2008 3Health News:Shengtai Pharmaceutical, Inc. Reports Third Quarter Results of Fiscal Year 2008 4Health News:Shengtai Pharmaceutical, Inc. Reports Third Quarter Results of Fiscal Year 2008 5Health News:Shengtai Pharmaceutical, Inc. Reports Third Quarter Results of Fiscal Year 2008 6Health News:Shengtai Pharmaceutical, Inc. Reports Third Quarter Results of Fiscal Year 2008 7Health News:Shengtai Pharmaceutical, Inc. Reports Third Quarter Results of Fiscal Year 2008 8Health News:Shengtai Pharmaceutical, Inc. Reports Third Quarter Results of Fiscal Year 2008 9Health News:Shengtai Pharmaceutical, Inc. Reports Third Quarter Results of Fiscal Year 2008 10Health News:Shengtai Pharmaceutical, Inc. Reports Third Quarter Results of Fiscal Year 2008 11Health News:Shengtai Pharmaceutical, Inc. Reports Third Quarter Results of Fiscal Year 2008 12Health News:IDM Pharma Announces Presentations at 44th American Society of Clinical Oncology Annual Meeting 2Health News:IDM Pharma Announces Presentations at 44th American Society of Clinical Oncology Annual Meeting 3Health News:Separation from mom, dad linked with learning trouble in kids 2Health News:Separation from mom, dad linked with learning trouble in kids 3
(Date:2/27/2015)... , February 27, 2015 Report ... study showing you trends, R&D progress, and predicted revenues ... heading? What are the commercial prospects for this market ... potential revenues and other trends to 2025, discussing data, ... lets you assess regenerative medicine : cell-based therapies ...
(Date:2/27/2015)... PRUSSIA, Pa. , Feb. 27, 2015  In ... its ongoing commitment to the global bleeding disorders community, ... donating 2 million international units (IUs) of protein therapies ... an international not-for- profit organization which has worked to ... inherited bleeding disorders. The donation supports the WFH,s Global ...
(Date:2/27/2015)... 2015  PTC Therapeutics, Inc. (NASDAQ: PTCT ... results for the fourth quarter and full year ended ... transformative year for PTC. We are now a growing ... therapies in the rare disease space," stated Stuart W. ... are proud to bring the first treatment for Duchenne ...
Breaking Medicine Technology:Translational Regenerative Medicine: Market Prospects 2015-2025 2Translational Regenerative Medicine: Market Prospects 2015-2025 3Translational Regenerative Medicine: Market Prospects 2015-2025 4Translational Regenerative Medicine: Market Prospects 2015-2025 5Translational Regenerative Medicine: Market Prospects 2015-2025 6Translational Regenerative Medicine: Market Prospects 2015-2025 7Translational Regenerative Medicine: Market Prospects 2015-2025 8CSL Behring Continues Treatment Access Leadership by Donating Bleeding Disorder Protein Therapies IUs to World Federation of Hemophilia 2CSL Behring Continues Treatment Access Leadership by Donating Bleeding Disorder Protein Therapies IUs to World Federation of Hemophilia 3PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 10PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 11
... CAMBRIDGE, England, March 14, 2012  Mundipharma International has ... business development operations. In this position, Mr. Medeiros ... a critical role in extending and expanding avenues ... companies, many of which are growing faster than ...
... shoulder injuries will now have an inexpensive and safe way to ... home for about the cost of one co-payment. Previously, ... rent a machine for hundreds of dollars per week or have ... is a patented shoulder pulley system that enables these exercises to ...
Cached Medicine Technology:Mundipharma's Commitment to Accelerated Business Growth Supported by Appointment of Paul Medeiros to Head Its Corporate and Business Development 2
Diagnostic and laboratory test reference. Get help with test preparation, interpretation, follow-up, and reimbursement....
... STELLARA™ is HIPAA-compliant wireless technology ... key hospital departments and personnel a ... in four tages or levels ... of patient care, shorter hospital stays ...
... Focus from Thermo Labsystems was designed specifically ... Advanced features such as the new fast ... on microvolumes help to define this as ... The new interchangeable handle plate offers a ...
... Focus from Thermo Labsystems was designed specifically ... Advanced features such as the new fast ... on microvolumes help to define this as ... The new interchangeable handle plate offers a ...
Medicine Products: